BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 2141672)

  • 1. The effects of L-vesamicol, an inhibitor of vesicular acetylcholine uptake, on two populations of miniature endplate currents at the snake neuromuscular junction.
    Searl T; Prior C; Marshall IG
    Neuroscience; 1990; 35(1):145-56. PubMed ID: 2141672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post- and presynaptic effects of vesamicol (AH5183) on the frog neuromuscular junction.
    Enomoto K
    Eur J Pharmacol; 1988 Mar; 147(2):209-15. PubMed ID: 3366175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of single quantal efficacy at the snake neuromuscular junction.
    Wilkinson RS; Lunin SD; Stevermer JJ
    J Physiol; 1992 Mar; 448():413-36. PubMed ID: 1350638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of quantal size by vesamicol (AH5183), an inhibitor of vesicular acetylcholine storage.
    Whitton PS; Marshall IG; Parsons SM
    Brain Res; 1986 Oct; 385(1):189-92. PubMed ID: 3768717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing quantal size at the mouse neuromuscular junction and the role of choline.
    Yu SP; Van der Kloot W
    J Physiol; 1991 Feb; 433():677-704. PubMed ID: 1841963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylcholine recycling and release at rat motor nerve terminals studied using (-)-vesamicol and troxpyrrolium.
    Searl T; Prior C; Marshall IG
    J Physiol; 1991 Dec; 444():99-116. PubMed ID: 1668355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A further study of the neuromuscular effects of vesamicol (AH5183) and of its enantiomer specificity.
    Estrella D; Green KL; Prior C; Dempster J; Halliwell RF; Jacobs RS; Parsons SM; Parsons RL; Marshall IG
    Br J Pharmacol; 1988 Apr; 93(4):759-68. PubMed ID: 3260527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of protein kinase C increases acetylcholine release from frog motor nerves by a direct action on L-type Ca(2+) channels and apparently not by depolarisation of the terminal.
    Arenson MS; Evans SC
    Neuroscience; 2001; 104(4):1157-64. PubMed ID: 11457598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repetitive nerve stimulation decreases the acetylcholine content of quanta at the frog neuromuscular junction.
    Naves LA; Van der Kloot W
    J Physiol; 2001 May; 532(Pt 3):637-47. PubMed ID: 11313435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of vesamicol on trains of endplate currents and on focally recorded nerve terminal currents at mammalian neuromuscular junctions.
    Pemberton KE; Prior C; Marshall IG
    Br J Pharmacol; 1992 Jan; 105(1):113-8. PubMed ID: 1375854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synaptic depression in frog neuromuscular junction.
    Glavinović MI
    J Neurophysiol; 1987 Jul; 58(1):230-46. PubMed ID: 2441003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiological and regenerative acetylcholine release from motor nerve: differential inhibitions by vesamicol and omega-agatoxin IVA.
    Hong SJ; Lee SH; Chang CC
    Neuroscience; 1995 Jul; 67(1):169-75. PubMed ID: 7477897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In favour of the vesicular hypothesis: neurochemical evidence that vesamicol (AH5183) inhibits stimulation-evoked release of acetylcholine from neuromuscular junction.
    Vizi ES
    Br J Pharmacol; 1989 Nov; 98(3):898-902. PubMed ID: 2590773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of an L-type Ca2+ channel antagonist on activity- and phosphorylation-enhanced release of acetylcholine at the neuromuscular junction of the frog in vitro.
    Arenson MS; Gill DS
    Eur J Neurosci; 1996 Mar; 8(3):437-45. PubMed ID: 8963434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of nerve terminal activity on non-quantal release of acetylcholine at the mouse neuromuscular junction.
    Zemková H; Vyskocil F; Edwards C
    J Physiol; 1990 Apr; 423():631-40. PubMed ID: 2388160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of veratridine on miniature endplate current amplitudes at the rat neuromuscular junction and acetylcholine uptake by Torpedo synaptic vesicles.
    Pemberton KE; Nguyen ML; Prior C; Parsons SM; Marshall IG
    Brain Res; 1995 Feb; 671(2):267-74. PubMed ID: 7743214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes of quantal transmitter release caused by gadolinium ions at the frog neuromuscular junction.
    Molgó J; del Pozo E; Baños JE; Angaut-Petit D
    Br J Pharmacol; 1991 Sep; 104(1):133-8. PubMed ID: 1686201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of an inhibitor of the synaptic vesicle acetylcholine transport system on quantal neurotransmitter release: an electrophysiological study.
    Lupa MT
    Brain Res; 1988 Sep; 461(1):118-26. PubMed ID: 3265645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presynaptic and postsynaptic effects of the venom of the Australian tiger snake at the neuromuscular junction.
    Datyner ME; Gage PW
    Br J Pharmacol; 1973 Oct; 49(2):340-54. PubMed ID: 4367126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical modification of vesamicol binding sites and frequency augmentation-potentiation in neuromuscular transmission.
    Maeno T; Enomoto K; Sawada M; Ichinose M
    Jpn J Physiol; 1994; 44(6):705-16. PubMed ID: 7760524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.